BNO
Click for more information
0.00% 1.0¢ bionomics limited

News: BNO Bionomics Announces Results Of BNC210 Agitation Trial

  1. Hot News
    190,074 Posts.
    lightbulb Created with Sketch. 2787
    clock Created with Sketch.
    26/06/19
    10:10
    Post #: 39241375

    June 26 (Reuters) - Bionomics Ltd (BNO) :

    • RESULTS OF AGITATION TRIAL INDICATED THAT BNC210 TREATMENT DID NOT DIFFERENTIATE FROM PLACEBO ON PRIMARY & SECONDARY EFFICACY END POINTS
    • TRIAL RESULTS DO NOT SUPPORT FURTHER DEVELOPMENT OF BNC210 FOR TREATMENT OF AGITATION, TO INVEST IN PURSUING DOSE STUDY FOR PTSD
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.